Please login to the form below

Not currently logged in
Email:
Password:

Patrick Fabbio named CFO at electroCore

He joins from NPS Pharmaceuticals where he was VP finance

edit-patrick-fabbio-of-electrocoreUS-based electroceutical healthcare company electroCore has named Patrick Fabbio as chief financial officer.

Fabbio has over 20 years of financial leadership experience in public and private life science and pharmaceutical companies, most recently as VP finance for NPS Pharmaceuticals.

During his time at NPS, he led the build-out of the global finance department and supported its $5.2bn sale to Shire in February of this year.

Prior to NPS, Fabbio served in a range of senior financial positions including VP finance at Catalent Pharma Solutions, CFO at Ikano Therapeutics and senior corporate finance, commercial and transactional roles at Sanofi.

ElectroCore founder and CEO JP Errico commented: "I am delighted that Pat has joined the electroCore team. Pat is a senior executive with broad experience in general management and finance. He has a strong track record of success in corporate finance in the healthcare sector.”

10th June 2015

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Peter Jackson
Rethinking our approach to infectious disease preparedness
The importance of long-term strategic investment to prepare for the next threat that emerges...
New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....

Infographics